Effects of Eicosapentaenoic Acid on Molecular, Metabonomics and Intestinal Microbiota Changes, in Subjects With Long-standing Inflammatory Bowel Disease
Phase of Trial: Phase I/II
Latest Information Update: 21 Sep 2015
At a glance
- Drugs Eicosapentaenoic acid (Primary)
- Indications Ulcerative colitis
- Focus Pharmacodynamics
- Acronyms EPAUC
- 17 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jun 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Aug 2015 as reported by ClinicalTrials.gov.
- 23 Oct 2014 Planned primary completion date changed from 1 Nov 2014 to 1 Apr 2015 according to ClinicalTrials.gov record.